ConductScience.org, home

Paper39166327

Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.

Yu M and 12 others. Circulation, 2024. Cited by 102 papers, by iCite.

Cite this record

ConductScience Library. Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial. Papers, record 39166327. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39166327

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effect of Colchicine on Coronary Plaque Stability in Acute Coronary Syndrome as Assessed by Optical Coherence Tomography: The COLOCT Randomized Clinical Trial.
PubMed
Journal
Circulation
PubMed
Year
2024
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
102
iCite
Relative citation ratio, by iCite
14.19, provisional
iCite
Revised in PubMed
2025-02-04
PubMed

Authors13

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ColchicineMajor topic
Acute Coronary SyndromeMajor topic
Tomography, Optical CoherenceMajor topic
Plaque, AtheroscleroticMajor topic
Humans
Female
Middle Aged
Male
Double-Blind Method
Aged
Prospective Studies
Adult
Treatment Outcome
Coronary Artery Disease

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT04848857Colchicine for the Stability of Coronary Plaque in Acute Coronary Syndrome (COLOCT)Derived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in39325503Colchicine and Atherothrombosis: Another Piece of the Puzzle.https://conductscience.org/library/papers/39325503

Source PubMed

Download CSV of comments and corrections

Cited by62

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 102 citations.

PMIDTitleJournalYearIn PapersSource
42888064Taming inflammation in coronary artery disease: lessons learned, translational breakthroughs, and future directions.Sci Bull (Beijing)2026https://conductscience.org/library/papers/42888064PubMed
42676490Beyond lipids: a precision prevention blueprint for China's residual risk.Front Med (Lausanne)2026https://conductscience.org/library/papers/42676490PubMed
42440890Advances in the Diagnosis and Management of Acute Coronary Syndrome: A Clinical Review.Cureus2026https://conductscience.org/library/papers/42440890PubMed
42438017Atherosclerotic Cardiovascular Disease and Cancer.Immunol Rev2026https://conductscience.org/library/papers/42438017PubMed
42437951Anti-inflammatory agents in atherosclerosis-and a need for reform: Extraordinary claims require extraordinary evidence.J Intern Med2026https://conductscience.org/library/papers/42437951PubMed
42346504Colchicine in Coronary Artery Disease-Too Much of a Good Thing?J Cardiovasc Dev Dis2026https://conductscience.org/library/papers/42346504PubMed
42279002Anti-Inflammatory Therapies in Acute Coronary Syndromes-A Review of Immunological, Genetic, and Clinical Challenges for Precision Medicine.J Clin Med2026https://conductscience.org/library/papers/42279002PubMed
42196392Colchicine in Cardiovascular Disease: Evidence Structure, Clinical Efficacy, Safety, and Translational Positioning Across Cardiovascular Syndromes.Int J Mol Sci2026https://conductscience.org/library/papers/42196392PubMed
42181649
Efficacy and safety of Shenqi Yangxin formula in patients with stable coronary artery disease based on CCTA: rationale, design, and study protocol for a randomized, double-blind, placebo-controlled study.
Front Cardiovasc Med2026https://conductscience.org/library/papers/42181649PubMed
42163171Joint effects of dyslipidemia and the platelet count on stroke risk: Longitudinal analysis via dynamic lipid stratification in the CHARLS cohort.BMC Neurol2026https://conductscience.org/library/papers/42163171PubMed
42051358Beyond the conventional risk factors in the management of atherosclerosis in women: a call to action for careful consideration of obesity and inflammation.Eur Heart J Open2026https://conductscience.org/library/papers/42051358PubMed
42045490Mechanisms and therapeutic potential of colchicine in atherosclerotic cardiovascular disease.Nat Cardiovasc Res2026https://conductscience.org/library/papers/42045490PubMed
42033599Cardiovascular Benefit and Gastrointestinal Risk of Colchicine in Secondary Prevention: Risk Associated with Dose and Treatment Duration.Am J Cardiovasc Drugs2026https://conductscience.org/library/papers/42033599PubMed
41997618Association between C reactive protein and risk of incident heart failure in cancer survivors.Open Heart2026https://conductscience.org/library/papers/41997618PubMed
41892853The Mental Health-Acute Coronary Syndrome Continuum: Bidirectional Pathophysiological Links and Clinical Implications.Med Sci (Basel)2026https://conductscience.org/library/papers/41892853PubMed
41832514M1 macrophage-derived migrasomes exacerbate post-myocardial infarction injury via guanylate binding protein 5.J Nanobiotechnology2026https://conductscience.org/library/papers/41832514PubMed
41827096Intracoronary Imaging for the Management of Vulnerable Plaques.J Clin Med2026https://conductscience.org/library/papers/41827096PubMed
41667721Inhibition of STING pathway attenuates experimental abdominal aortic aneurysm progression.Acta Pharmacol Sin2026https://conductscience.org/library/papers/41667721PubMed
41593670Neutrophil methylmalonic acid promotes microthrombus formation and adverse cardiac remodeling post-myocardial infarction through activating IL-6 signaling pathway-mediated NETosis.BMC Med2026https://conductscience.org/library/papers/41593670PubMed
41568554Colchicine in Patients With Recent Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.J Am Heart Assoc2026https://conductscience.org/library/papers/41568554PubMed

See all 62 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CRP1401PubTator's text mininghttps://conductscience.org/library/genes/1401NCBI Gene
MPO4353PubTator's text mininghttps://conductscience.org/library/genes/4353NCBI Gene

Download CSV of genes

Drugs1

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targets
COLCHICINECHEMBL107Derived from the trial1https://conductscience.org/library/drugs/CHEMBL107

Source ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • References
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39166327

GET https://conductscience.org/api/papers/v1/39166327/cited_by?page=2